ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,362.40
-0.09%
Dow Jones
39,671.04
-0.51%
Gold vs US Dollar
2,361.83
-0.84%
Brent Oil
81.465
-0.08%
Bitcoin
69,486.42
0.55%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Taro Pharmaceutical Industries Ltd (TARO)

  7. Taro Pharmaceutical Industries Ltd (TARO) News

Taro Pharmaceutical Indu... (TARO)

Taro Pharmaceutical Industries Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:TARO
DateTimeSourceHeadlineSymbolCompany
21/05/202414:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
20/05/202422:00Business WireTaro Provides Results for Year Ended March 31, 2024NYSE:TAROTaro Pharmaceutical Industries Ltd
15/05/202414:00Business WireTaro to Release Full Year Results on May 20, 2024NYSE:TAROTaro Pharmaceutical Industries Ltd
14/05/202413:20Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
08/05/202414:28Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
08/05/202414:07Business WireLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma MergerNYSE:TAROTaro Pharmaceutical Industries Ltd
15/04/202413:00Business WireTaro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.NYSE:TAROTaro Pharmaceutical Industries Ltd
11/03/202410:19Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
15/02/202413:36Edgar (US Regulatory)Form SC 13E3 - Going private transaction by certain issuersNYSE:TAROTaro Pharmaceutical Industries Ltd
30/01/202418:18PR Newswire (US)Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law FirmNYSE:TAROTaro Pharmaceutical Industries Ltd
30/01/202412:00PR Newswire (US)Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for TaroNYSE:TAROTaro Pharmaceutical Industries Ltd
26/01/202414:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
25/01/202422:06Business WireTaro Provides Results for December 31, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
19/01/202421:15Business WireTaro to Release Third Quarter Results on January 25, 2024NYSE:TAROTaro Pharmaceutical Industries Ltd
17/01/202421:36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
17/01/202421:35Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
17/01/202421:30PR Newswire (Canada)Taro Announces Merger Agreement with Sun PharmaNYSE:TAROTaro Pharmaceutical Industries Ltd
17/01/202421:30PR Newswire (US)Taro Announces Merger Agreement with Sun PharmaNYSE:TAROTaro Pharmaceutical Industries Ltd
04/01/202421:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
11/12/202321:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
11/12/202321:30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NYSE:TAROTaro Pharmaceutical Industries Ltd
17/11/202321:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
27/10/202314:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
26/10/202322:00Business WireTaro Provides Results for September 30, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
19/10/202321:30Business WireTaro to Release Second Quarter Results on October 26, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
27/07/202315:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:TAROTaro Pharmaceutical Industries Ltd
27/07/202301:36Business WireTaro Provides Results for the Quarter Ended June 30, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
19/07/202321:00Business WireTaro to Release First Quarter Results on July 26, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
19/07/202312:00PR Newswire (US)Krensavage Asset Management Opposes Sun's Lowball Bid for TaroNYSE:TAROTaro Pharmaceutical Industries Ltd
30/06/202314:00Business WireTaro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023NYSE:TAROTaro Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TARO

Your Recent History

NYSE
LDOS
Leidos
NYSE
TCN
Tricon Residential
USOTC
PHNMF
Phenom Resources (QX)
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved